FDA Employs Carrot, Stick Under Unapproved Drug Enforcement Strategy
This article was originally published in The Tan Sheet
Executive Summary
Unapproved drugs that "present direct challenges" to FDA's new drug approval and OTC drug monograph systems will be high priority for enforcement actions, according to an agency guidance released June 8